Medication info
Atorvastatin Calcium Trihydrate 10 mg Tablets

Atorvastatin Calcium Trihydrate 10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
White, round, film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307038 · Approved 2013.04.22 · Insurance code 640902490

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular disease (including myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. If LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular disease (including myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • revascularization
  • stable chronic angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It is particularly used to lower the risk of myocardial infarction and stroke in high-risk adult patients or those with type 2 diabetes, and to prevent the occurrence of revascularization procedures and angina. Additionally, it reduces the risk of hospitalization due to myocardial infarction, stroke, and congestive heart failure, and is effective in improving angina in patients with established clinical evidence of coronary heart disease. Furthermore, it improves blood lipid levels by lowering cholesterol and bad LDL levels while raising good HDL levels in patients with hyperlipidemia. It also helps reduce total cholesterol and LDL cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. Therefore, this drug is used for the reduction of cardiovascular disease risk and the improvement of dyslipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. If LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication should be discontinued immediately if serious muscle-related adverse effects appear, especially if there is muscle pain, weakness, or a significant increase in muscle enzyme levels. It should not be used by patients with certain diseases or those taking specific medications. For example, patients with severely impaired liver function, women who are pregnant or breastfeeding, children under 10 years of age, and individuals with hypersensitivity to this drug should not take it. Patients with a history of liver disease or alcohol addiction should use this medication with more caution, and those with a history of muscle disease should also be careful. Elderly patients or those with impaired kidney function are at higher risk of muscle-related adverse effects and should be closely monitored. This drug can affect liver function; therefore, regular liver function tests should be conducted before and during treatment. If symptoms of hepatitis or jaundice appear, consult a doctor immediately. This medication may interact with other drugs, so patients should inform their doctor or pharmacist of all medications they are currently taking. Caution is especially needed when co-administering with certain antibiotics, antifungals, antivirals, and some cardiovascular medications. Women planning to become pregnant or of childbearing age should use adequate contraceptive methods while taking this medication and discontinue its use immediately upon confirmation of pregnancy. Breastfeeding women should not take this medication. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, inform medical personnel immediately and undergo testing, as these symptoms could indicate severe muscle damage. There is no specific antidote for overdose; therefore, appropriate treatment should be administered depending on the symptoms, and liver function and muscle enzyme levels should be closely monitored. Finally, keep this medication out of the reach of children and store it in its original container, as transferring it to another container may pose a risk of misuse or deterioration of quality.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 171 more
  • anorexia
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngodynia
  • laryngodynia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensory disturbances
  • paresthesia
  • taste disturbances
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • muscle rupture
  • lupus-like syndrome
  • tendon disorders
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • vascular edema
  • angioedema
  • erythema multiforme
  • blistering dermatitis
  • mucous membrane pemphigoid
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • urinary leukocyte positive
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial somnolence
  • bronchitis
  • rhinitis
  • pneumonia
  • respiratory distress
  • asthma
  • sensory abnormalities
  • dizziness
  • photosensitivity reactions
  • drowsiness
  • amnesia
  • abnormal dreams
  • decreased libido
  • anxiety disorders
  • motor coordination ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • increased tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • appetite stimulation
  • vascular neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive disorders
  • ocular hemorrhage
  • auditory loss
  • glaucoma
  • corneal opacity
  • taste loss
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness over time.

Appearance and packaging

Appearance

White, round, film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.